Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate Bedrin

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|August 19, 2022
Atogepant for migraineKate Bedrin, Jessica Ailani
Frontiers in Pain Research (Lausanne, Switzerland)|April 3, 2023
Calcitonin gene relating peptide inhibitors in combination for migraine treatment: A mini-reviewTulsi Shah, Kate Bedrin, Amanda Tinsley
Headache|November 25, 2022
Raynaud's phenomenon associated with calcitonin gene-related peptide receptor antagonists case reportKate Bedrin, Jessica Ailani, Carrie Dougherty
Current Neurology and Neuroscience Reports|July 17, 2024
CGRP Modulating Therapies: An UpdateKate Bedrin, Tulsi Shah, Shivani Vaidya, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Drugs of Today (Barcelona, Spain : 1998)|August 19, 2022
Atogepant for migraineKate Bedrin, Jessica Ailani
Frontiers in Pain Research (Lausanne, Switzerland)|April 3, 2023
Calcitonin gene relating peptide inhibitors in combination for migraine treatment: A mini-reviewTulsi Shah, Kate Bedrin, Amanda Tinsley
Headache|November 25, 2022
Raynaud's phenomenon associated with calcitonin gene-related peptide receptor antagonists case reportKate Bedrin, Jessica Ailani, Carrie Dougherty
Current Neurology and Neuroscience Reports|July 17, 2024
CGRP Modulating Therapies: An UpdateKate Bedrin, Tulsi Shah, Shivani Vaidya, et al.
Pageof 1